The size of the Radiotherapy Market in North America was worth $2.02 billion in 2020 and estimated to be growing at a CAGR of 5.54% to reach USD 2.64 billion by 2025.
North America is the utmost vibrant, extremely competitive, and the leading market for radiotherapy devices globally. The market growth is considerably higher in North America since it is continuously inclined to the usage of novel technologies. Radiation therapy practices high energy radiation on directed cells and cell progression to stop them from growing and distributing. Emissions are mainly from an external machine or from implants i.e., an internal mechanism that is placed near the tumors. This technique is widely used for the treatment of a cancerous tumor, benign tumors, and other conditions like thyroid disease and some blood disorders.
North American Radiotherapy Market is driven by quickly altering cancer treatment technology and an increasing number of cancer patients. Technological advancements also drive growth in biological and molecular imaging techniques that permit radiotherapy to be progressively personalized for patient needs. Emerging healthy reimbursement plans and untapped markets in few areas are also few factors fuelling the growth of the radiotherapy market.
Major factors inhibiting the growth of the market are healthcare expenditure and alternative treatment procedures.
This research report segmented and sub-segmented into the following categories:
Based on the application, the prostate cancer application segment is estimated to hold the largest share in both the external beam radiotherapy market along with the internal radiotherapy market.
Key Developments in the Market
Companies playing a dominant role in the North America Radiotherapy Market profiled in this report are Nordion Inc., RaySearch Laboratories AB, Ion Beam Applications SA, C. R. Bard Inc., Mevion Medical Systems Inc., Varian Medical Systems Inc., IsoRay Medical Inc., Elekta AB, Accuray Incorporated and Mitsubishi Electric Corporation.
This report helps to understand
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Type
5.1.1 External Beam Radiation Therapy
188.8.131.52 Intensity-Modulated Radiation Therapy (IMRT)
184.108.40.206 Image-Guided Radiation Therapy (IGRT)
220.127.116.11 Stereotactic Radiosurgery
18.104.22.168 Stereotactic body Radiation Therapy
22.214.171.124 Proton Therapy
5.1.2 Internal Beam Radiation Therapy
5.1.3 Systemic Radiation Therapy
5.2 By Application
5.2.1 Skin & Lip Cancer
5.2.2 Head & Neck Cancer
5.2.3 Breast Cancer
5.2.4 Prostate Cancer
5.2.5 Cervical Cancer
5.2.6 Lung Cancer
5.2.7 Spine Cancer
5.3 By Equipment Type
5.3.1 Linear Accelerators
5.3.2 Radiation Therapy Simulators
5.3.3 Treatment Planning Systems
6. Geographical Analysis
6.2 United States
7. Pipeline Product Analysis
7.2 Pipeline Development Landscape
7.3 Molecular Targets in the Pipeline
7.4 Clinical Trials
7.4.1 Failure Rate by Stage of Development, Indication, Molecule Type and Molecular Target
7.4.2 Clinical Trial Duration by Stage of Development, Indication, Molecule Type and Molecular Target
7.4.3 Clinical Trial Size by Stage of Development, Indication, Molecule Type and Molecular Target.
8. Strategic Analysis
8.1 PESTLE analysis
8.2 Porter’s Five analysis
8.2.1 Bargaining Power of Suppliers
8.2.2 Bargaining Power of Consumers
8.2.3 Threat of New Entrants
8.2.4 Threat of Substitute Products and Services
8.2.5 Competitive Rivalry within the Industry
9. Market Leaders' Analysis
9.1 Nordion Inc.
9.1.2 Product Analysis
9.1.3 Strategic Evaluation and Operations
9.1.4 Financial analysis
9.1.5 Legal issues
9.1.6 Recent Developments
9.1.7 SWOT analysis
9.1.8 Analyst View
9.2 RaySearch Laboratories AB
9.3 Ion Beam Applications SA
9.4 C. R. Bard Inc.
9.5 Mevion Medical Systems Inc.
9.6 Varian Medical Systems Inc.
9.7 IsoRay Medical Inc.
9.8 Elekta AB
9.9 Accuray Incorporated
9.10 Mitsubishi Electric Corporation
10. Competitive Landscape
10.1 Market share analysis
10.2 Merger and Acquisition Analysis
10.3 Agreements, collaborations and Joint Ventures
10.4 New Product Launches
11. Expert Opinions
11.1 Market Outlook
11.2 Investment Opportunities
a) List of Tables
b) List of Figures